Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer

PURPOSE: An open-label Phase 1 study of recombinant prime-boost poxviruses targeting CEA and MUC-1 in patients with advanced pancreatic cancer was conducted to determine safety, tolerability and obtain preliminary data on immune response and survival. PATIENTS AND METHODS: Ten patients with advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaufman, Howard L, Kim-Schulze, Seunghee, Manson, Kelledy, DeRaffele, Gail, Mitcham, Josephine, Seo, Kang Seok, Kim, Dae Won, Marshall, John
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2217514/
https://www.ncbi.nlm.nih.gov/pubmed/18039393
http://dx.doi.org/10.1186/1479-5876-5-60

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2217514/
https://www.ncbi.nlm.nih.gov/pubmed/18039393
http://dx.doi.org/10.1186/1479-5876-5-60

Ejemplares similares